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SAT0718-HPR INFLUENCE OF PATIENT GLOBAL ASSESSMENT ON THE DISEASE ACTIVITY ASSESSMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS: A METEOR CROSS-SECTIONAL STUDY
Background: Disease activity indices (DAI) are used to guide immunosuppressive therapy in rheumatoid arthritis (RA). The inclusion of patient global assessment (PGA) in these indices has been questioned as it conveys mainly disease impact rather than disease activity. Objectives: To determine the influence of PGA on patient disease states and to determine PGA correlations with inflammatory parameters, disease impact, demographic, clinical and contextual factors. Methods: The METEOR international database was used, namely data from patients' first available visit with no missing values on PGA, tender and swollen joint counts (TJC28, SJC28) and C-reactive protein (CRP). Remission rates were compared according to the DAS28CRP3v vs 4v and ACR/EULAR Boolean remission vs near-remission (failing 1 of the 4 criteria) definition. We assessed the correlation of PGA with (predominantly) inflammatory (TJC28, SJC28, CRP) and disease impact (pain and HAQ) factors. We used hierarchical modelling to explain PGA by 4 blocks (B) of independent variables (B1: gender, age, disease duration; B2: biologic DMARD, Gross National Income; B3: pain, HAQ; and B4: TJC28, SJC28, CRP). Results: Among the 18280 patients analysed, 1930 (10.6%) were in DAS28CRP4v remission, and 2197 (12.0%) in DAS28CRP3v remission. According to the Boolean definition, 1207 (6.6%) patients were in remission. PGA was the main obstacle to Boolean remission: 2090 (79.0%) of the 2645 near-remission patients (Table 1) . A considerable proportion of patients with low inflammation perceived high PGA (Figure 1) . PGA correlated better with Pain (r p =.79) and HAQ (r p =.55) than with TJC28 (r p =.45), SJC28 (r p =.36) or CRP (r p =.25). In the entire dataset, 60.2% of PGA variance was explained by Pain and HAQ, 1.8% by B1 and B2 of covariates and only 1.3% by B4 (TJC28, SJC28, CRP) ( Table 2 ). In near-remission patients, B4 did not contribute significantly to changes in the model. Legend: B1 = Gender + Age + Dis. duration; B2 = B1 + Gross Nat. Income + bDMARD; B3 = B1 + B2 + Pain + HAQ; B4 = B1 + B2 + B3 + TJC28, SJC28, CRP.
Conclusions:
Two thirds of patients that achieve TJC28, SJC28, and CRP≤1 still perceive high PGA despite disease "inflammatory" control. 
